Susquehanna International Group
LYRA

Susquehanna International Group’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Susquehanna International Group’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,351
Closed -$27.5K – 13282
2025
Q1 		$27.5K Buy
4,351
+2,282
+110% +$21.3K ﹤0.01% 12035
2024
Q4 		$21.3K Buy
2,069
+1,811
+702% +$19.9K ﹤0.01% 11903
2024
Q3 		$3.32K Sell
258
-445
-63% -$6.54K ﹤0.01% 11773
2024
Q2 		$9.73K Sell
703
-6,163
-90% -$697K ﹤0.01% 11780
2024
Q1 		$2.14M Buy
6,866
+1,678
+32% +$447K ﹤0.01% 5184
2023
Q4 		$1.36M Buy
5,188
+1,931
+59% +$349K ﹤0.01% 6220
2023
Q3 		$637K Buy
3,257
+3,019
+1,268% +$540K ﹤0.01% 7672
2023
Q2 		$48.8K Buy
+238
New +$33K ﹤0.01% 11348
2023
Q1 		– Sell
-272
Closed -$42.6K – 13114
2022
Q4 		$42.6K Sell
272
-159
-37% -$31.5K ﹤0.01% 11475
2022
Q3 		$108K Buy
+431
New +$127K ﹤0.01% 11627
2022
Q1 		– Sell
-224
Closed -$49K – 13574
2021
Q4 		$49K Sell
224
-94
-30% -$30.2K ﹤0.01% 12557
2021
Q3 		$145K Sell
318
-113
-26% -$42.7K ﹤0.01% 11819
2021
Q2 		$173K Buy
+431
New +$196K ﹤0.01% 11738

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group's LYRA Position: Q2 2025 in Review

Susquehanna International Group sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 4,351 shares — an estimated $27.5K sold.

Susquehanna International Group first reported a position in LYRA in Q2 2021 and held it in 13 quarters. The position peaked at $2.14M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Susquehanna International Group reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 4,351 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $27.5K.
  • Susquehanna International Group first reported a position in LYRA THERAPEUTICS INC in Q2 2021 and held it in 13 quarters.
  • Susquehanna International Group's LYRA THERAPEUTICS INC position peaked at $2.14M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.